Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine

Clinical trial NCT01309646 · COMPLETED

Trial details

NCT number: NCT01309646
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Poliomyelitis Tetanus Acellular Pertussis Diphtheria Haemophilus Influenzae Type b

Start date: 2011-03-04
Primary completion: 2012-02-24
Enrollment: 454

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.